1. 632 HPN601 is a protease-activated EpCAM-targeting T cell engager with an improved safety profile for the treatment of solid tumors. (9th November 2020) Authors: Lin, Jack; Rocha, Sony; Kwant, Kathryn; Dayao, Maria; Ng, Tessie; Aaron, Wade; Callihan, Evan; Gamez-Guerrero, Maria; Hemmati, Golzar; Wright, Kevin; Barath, Manasi; Xiao, Yinghua; Degree, Master; Yu, Timothy; Chew, Patrick; Evans, Thomas; O'Rear, Jessica; Gatto, Scott; Cremin, Michael; Yu, Stephen Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 632 HPN601 is a protease-activated EpCAM-targeting T cell engager with an improved safety profile for the treatment of solid tumors. (9th November 2020) Authors: Lin, Jack; Rocha, Sony; Kwant, Kathryn; Dayao, Maria; Ng, Tessie; Aaron, Wade; Callihan, Evan; Gamez-Guerrero, Maria; Hemmati, Golzar; Wright, Kevin; Barath, Manasi; Xiao, Yinghua; Degree, Master; Yu, Timothy; Chew, Patrick; Evans, Thomas; O'Rear, Jessica; Gatto, Scott; Cremin, Michael; Yu, Stephen Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗